Tesamorelin (10mg)

🧬 Tesamorelin – Research Overview

Lab Analysis Report

0. Category:
Muscle Growth / Strength, Fat Loss, Anti-Aging / Longevity, Metabolic Health

1. Primary Research Use:
Tesamorelin is primarily researched for its ability to stimulate growth hormone (GH) production, promote lipolysis (fat loss)—especially visceral (belly) fat—and improve body composition. It is also studied for its cognitive, anti-aging, and metabolic effects due to elevated endogenous GH and IGF-1 levels.

2. Simple Analogy:
Tesamorelin is like flipping the body’s “youth switch”—it sends a signal to the pituitary gland to naturally release more growth hormone, which helps burn deep belly fat and restore a more youthful hormonal environment.

3. What It Is (Chemical Summary):
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). It consists of 44 amino acids and is stabilized with a trans-3-hexenoic acid group, enhancing its biological half-life and potency.

4. Best Suited For:
This peptide is commonly researched by those studying growth hormone deficiency, body recomposition, visceral fat reduction, anti-aging interventions, and neurocognitive function. It is especially notable in studies involving belly fat loss in men over 40 and in HIV-associated lipodystrophy.

5. Not Recommended For / Caution In Research With:
Caution is advised when researching this peptide in individuals with:

• Active or past cancer (due to GH/IGF-1 proliferative concerns)
• Diabetes or insulin resistance (may affect glucose levels)
• Untreated thyroid disorders (can skew GH/IGF-1 feedback loops)

6. Synergistic Peptide Stacks:

• Ipamorelin – Combines well by promoting GH pulse without increasing cortisol/prolactin.
• CJC-1295 (no DAC) – Used together to extend the GH-release window and mimic youthful patterns.
• BPC-157 – Supports joint and tissue repair while Tesamorelin improves body composition.

7. Common Dosing Guidelines (Research Use):

Experience Level	Common Dosage Range
Beginner	1.0 mg per day
Intermediate	1.0–2.0 mg per day
Advanced	2.0 mg per day

Typical research protocol is 1 mg injected subcutaneously once daily, often at night to mimic natural GH release.

8. Cycling Information:
Research protocols often suggest 8–12 week cycles, followed by a 2–4 week break.
In longer-term studies (e.g., HIV lipodystrophy), continuous administration has shown efficacy with manageable safety profiles under medical supervision.
Common protocol:

• Cycle: 3 months on, 1 month off
• Long-term: Daily with monitoring of IGF-1 and glucose levels

9. Similar Peptides & Comparison Chart:

Peptide	Duration	Mechanism of Action	Dosing Frequency	Notes
Tesamorelin	Medium (hours)	GHRH analog	1x/day	FDA-approved for HIV lipodystrophy; visceral fat loss
CJC-1295	Long (7–14 d)	GHRH analog (with DAC)	1–2x/week	Long half-life, stable GH elevation
Sermorelin	Short (minutes–2 hrs)	GHRH analog	1–2x/day	Mimics natural GH pulses, shorter acting
Ipamorelin	Short (hours)	GHRP – stimulates GH release	2–3x/day	Pairs well with GHRH analogs for enhanced effect

---

10. Method of Administration:
Subcutaneous injection once daily, typically before bed or post-exercise to align with natural GH secretion cycles.

11. Regulatory Status (FDA Approval):
Tesamorelin is FDA-approved under the brand name Egrifta for the treatment of HIV-associated lipodystrophy (specifically, visceral adipose tissue reduction). Its use outside this indication is considered off-label or investigational.

12. Legal Disclaimer:
All products discussed are intended for laboratory, scientific, and research purposes only. These products are not approved by the FDA for human or veterinary use and are not intended to diagnose, treat, cure, or prevent any disease. They must not be used for any form of medical application or personal use.
The information presented is for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before making decisions regarding your health.
By accessing or purchasing these materials, you affirm that you are a qualified researcher or are acting under the supervision of one. All sales are final.